Building on the insights from our first four episodes, join us for the fifth installment of NCIA’s #IndustryEssentials multi-part webinar series, where we delve into the paradigm shift within the cannabis industry following the rescheduling of cannabis to a Schedule III drug. This session, led by our expert Cannabis Manufacturing Committee, will focus on the profound impacts and implications of rescheduling cannabis on the manufacturing sector. As we navigate these unprecedented changes, our panel of industry leaders will provide critical insights and practical guidance to help your business adapt and thrive in this new landscape.

Learning Objectives:

• Future of Manufacturing Post-Rescheduling
• GMP and Regulatory Requirements
• Focus on Extracts and Concentrates
• Impact of Big Pharma
• Best Practices for Non-Pharmaceutical Quality

Panelists:

This webinar will serve as a forum for member and non-member businesses under the “Cannabis Manufacturing” umbrella to come together and discuss the potential implications on their sector. Participants will have the opportunity to learn from subject matter experts on how best to prepare for and positively influence the outcome of this rescheduling process.

We encourage all participants to utilize the NCIA public comment tool to support the rescheduling of the legal cannabis industry by submitting their comments to the Department of Justice. Your voice is crucial in shaping the future regulatory landscape.